Artikelen door Mithra Pharmaceuticals

Mithra Pharmaceuticals releases 2016 Annual Report and invitation to its Ordinary General Shareholders’ Meeting

Liège, Belgium 18 April 2017 – Mithra Pharmaceuticals is pleased to announce the publication of its 2016 Annual Report and the invitation for its Ordinary General Shareholders’ meeting. Annual Report The Annual Report which outlines Mithra’s achievements in 2016 includes the following information: Overview of Mithra’s R&D pipeline and letter to shareholders; Highlights of Mithra’s […]

Mithra Pharmaceuticals releases 2016 Annual Report and invitation to its Ordinary General Shareholders’ Meeting

Liège, Belgium 18 April 2017 – Mithra Pharmaceuticals is pleased to announce the publication of its 2016 Annual Report and the invitation for its Ordinary General Shareholders’ meeting. Annual Report The Annual Report which outlines Mithra’s achievements in 2016 includes the following information: Overview of Mithra’s R&D pipeline and letter to shareholders; Highlights of Mithra’s […]

Mithra Pharmaceuticals releases 2016 Annual Report and invitation to its Ordinary General Shareholders’ Meeting

Liège, Belgium 18 April 2017 – Mithra Pharmaceuticals is pleased to announce the publication of its 2016 Annual Report and the invitation for its Ordinary General Shareholders’ meeting. Annual Report The Annual Report which outlines Mithra’s achievements in 2016 includes the following information: Overview of Mithra’s R&D pipeline and letter to shareholders; Highlights of Mithra’s […]

Mithra Agrees Exclusive Long-Term License and Supply Agreement with Mayne Pharma to Commercialize Myring in the US

Mithra grants its first exclusive license for its vaginal contraception ring, Myring, to Mayne Pharma (ASX: MYX), the second-largest supplier of oral contraceptives in the US market, covering commercialization in the United States As part of the agreement, Mayne Pharma will pay milestones of at least EUR 10.0m following approval by the US FDA Mithra […]

Mithra Agrees Exclusive Long-Term License and Supply Agreement with Mayne Pharma to Commercialize Myring in the US

Mithra grants its first exclusive license for its vaginal contraception ring, Myring, to Mayne Pharma (ASX: MYX), the second-largest supplier of oral contraceptives in the US market, covering commercialization in the United States As part of the agreement, Mayne Pharma will pay milestones of at least EUR 10.0m following approval by the US FDA Mithra […]

Mithra Agrees Exclusive Long-Term License and Supply Agreement with Mayne Pharma to Commercialize Myring in the US

Mithra grants its first exclusive license for its vaginal contraception ring, Myring, to Mayne Pharma (ASX: MYX), the second-largest supplier of oral contraceptives in the US market, covering commercialization in the United States As part of the agreement, Mayne Pharma will pay milestones of at least EUR 10.0m following approval by the US FDA Mithra […]

Mithra Granted EUR 1.9 million in Non-Dilutive Funding

Non-dilutive funding granted by the Walloon region Funding to support Estetrol (E4) and complex therapeutics solutions research projects Liège, Belgium, 13 February 2017, 07.30am CET – Mithra Pharmaceuticals (Euronext Brussels: MITRA), a company focused on women’s health, today announces that it has been granted EUR 1.9 million in non-dilutive funding from the Walloon Region. The […]

Mithra Strengthens Position in the Belgian Contraception Market

Mithra builds on leading position in Belgian contraceptive market Mithra achieves significant increase in 2016 sales Market trend validates Mithra’s Estetrol-based programs Liège, Belgium January 31, 2017 – Mithra Pharmaceuticals (Euronext Brussels: MITRA), a company focused on women’s health, today announces that it increased its market share in Belgium by 0.97% to 45.84% compared to […]

Mithra Strengthens Position in the Belgian Contraception Market

Mithra builds on leading position in Belgian contraceptive market Mithra achieves significant increase in 2016 sales Market trend validates Mithra’s Estetrol-based programs Liège, Belgium January 31, 2017 – Mithra Pharmaceuticals (Euronext Brussels: MITRA), a company focused on women’s health, today announces that it increased its market share in Belgium by 0.97% to 45.84% compared to […]

Mithra Strengthens Position in the Belgian Contraception Market

Mithra builds on leading position in Belgian contraceptive market Mithra achieves significant increase in 2016 sales Market trend validates Mithra’s Estetrol-based programs Liège, Belgium January 31, 2017 – Mithra Pharmaceuticals (Euronext Brussels: MITRA), a company focused on women’s health, today announces that it increased its market share in Belgium by 0.97% to 45.84% compared to […]